Violet Therapeutics
Company

Violet Therapeutics

Biotechnology Research Cambridge, Ma, United States 9 employees
Employees
9
Contacts
3
Emails
3
Phones
1

Violet Therapeutics Overview

Headquarters
Cambridge, Ma, United States
Industry
Biotechnology Research
Employees
9
Funding
10.6M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Violet Therapeutics

Violet Therapeutics is a pre-clinical stage company leveraging a first-in-class platforms to identify, map and mine cell-to-cell communication at scale. Violet’s drug discovery programs are focused on CNS diseases enabled by the novel targets elucidated by their platforms. Violet was co-founded in 2021 by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital.

Violet Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

Violet Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Robert Hubbard, Ph.d. Company Creation - Chief Scientific Officer - Drug Developer - Medicinal Chemist
Email Phone
Evan Lebois Cns Drug Discovery Expert
Email
Michael Wheeler Neuroimmunologist - Expert in Neuroimmune Circuits & Psychiatry - Innovator in Single-cell Tools - Harvard Assistant Professor - Biotech/vc-ready
View
Darby R. Schmidt Cso
Email

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
Associate / junior 1 profile

Compare Similar Companies to Violet Therapeutics